PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-40.45%
Negative revenue growth while FSLR stands at 67.25%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
144.12%
Gross profit growth at 75-90% of FSLR's 178.39%. Bill Ackman would demand operational improvements to match competitor gains.
83.79%
EBIT growth below 50% of FSLR's 311.75%. Michael Burry would suspect deeper competitive or cost structure issues.
81.76%
Operating income growth under 50% of FSLR's 311.75%. Michael Burry would be concerned about deeper cost or sales issues.
79.61%
Net income growth at 50-75% of FSLR's 119.18%. Martin Whitman would question fundamental disadvantages in expenses or demand.
79.66%
EPS growth at 50-75% of FSLR's 119.08%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
79.61%
Diluted EPS growth at 50-75% of FSLR's 118.84%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.49%
Share count expansion well above FSLR's 0.10%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.43%
Diluted share reduction more than 1.5x FSLR's 1.78%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Dividend reduction while FSLR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-587.06%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-259.95%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-19.36%
Negative 10Y revenue/share CAGR while FSLR stands at 117.84%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-47.70%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-16.30%
Negative 3Y CAGR while FSLR stands at 15.48%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-89.40%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-218.55%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-93.69%
Negative 3Y OCF/share CAGR while FSLR stands at 89.65%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-644.33%
Negative 10Y net income/share CAGR while FSLR is at 34.55%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-79.81%
Negative 5Y net income/share CAGR while FSLR is 16.99%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1039.85%
Negative 3Y CAGR while FSLR is 227.20%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-70.19%
Negative equity/share CAGR over 10 years while FSLR stands at 238.91%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-56.85%
Negative 5Y equity/share growth while FSLR is at 17.13%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-69.96%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.38%
AR growth well above FSLR's 4.90%. Michael Burry fears inflated revenue or higher default risk in the near future.
0.51%
Inventory shrinking or stable vs. FSLR's 19.00%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
4.23%
Positive asset growth while FSLR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
139.76%
BV/share growth above 1.5x FSLR's 1.09%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.20%
Debt shrinking faster vs. FSLR's 11.27%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-4.70%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-10.20%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.